Rare Diseases
Vaccine Supply for Healthcare Systems Worldwide
Product Overview
Rare diseases often present some of the most challenging sourcing requirements in healthcare, particularly when products are approved in limited markets or needed for small patient populations. OctaGenix has the capability to support the procurement of premium products for rare and ultra-rare conditions, helping bridge access gaps for healthcare providers and specialist centres.
- Ligula nascetur molestie vitae in
- Integer suscipit nisi magnis et
- Aenean elementum facilisi
- Tincidunt primis porttitor
- Ligula nascetur molestie vitae in
- Integer suscipit nisi magnis et
- Aenean elementum facilisi
- Tincidunt primis porttitor
Human Vaccine Categories We Can Support
As orphan drugs are usually very expensive, OctaGenix uses its global sourcing channels to identify and procure products at more affordable prices for healthcare systems, while maintaining a strong focus on quality, authenticity, and compliance. By improving cost-effective access to rare disease treatments, OctaGenix helps enhance patient access to essential therapies that may otherwise be difficult to obtain due to limited availability, high cost, or complex supply routes.
Other Products
Get in Contact?
Get in touch with our team to discuss product availability, procurement requirements, and how OctaGenix can support your healthcare supply needs.
| Product | Strength | Formulation |
|---|---|---|
| Bleomycin (Lyophilized) | 15 IU | Rare oncology / hematologic malignancy |
| Cytarabine | 100mg/ml; 500mg/5ml; 1000mg/10ml | Rare oncology / hematologic malignancy |
| Dactinomycin (Lyophilized) | 500mcg | Rare oncology / pediatric solid tumor |
| Daunorubicin (Lyophilized) | 20mg | Rare oncology / hematologic malignancy |
| Fludarabine | 50mg/2ml | Rare oncology / hematologic malignancy |
| L-Asparaginase (Lyophilized) | 5000 IU; 10000 IU | Rare oncology / acute lymphoblastic leukemia |
| Leuprolide | 3.75mg; 7.5mg; 11.25mg; 22.5mg | Rare endocrine / central precocious puberty |
| Pemetrexed (Lyophilized) | 100mg; 500mg | Rare oncology / mesothelioma |
| Temoporfin | 1mg/ml | Rare oncology / photodynamic therapy |
| Vincristine | 1mg/ml; 2mg/2ml | Rare oncology / hematologic or pediatric cancer |
| Pamidronate / Di-Sodium Pamidronate (Lyophilized) | 30mg; 60mg; 90mg | Rare bone disease / osteogenesis imperfecta use |
| Zoledronic Acid (Lyophilized) | 4mg | Rare bone disease / osteogenesis imperfecta use |
| Desmopressin | 4mcg/ml | Rare endocrine / central diabetes insipidus |
| Somatropin (HGH) | 4 IU; 10 IU; 12 IU; 16 IU; 24 IU | Rare endocrine / genetic growth disorder |
| Octreotide | 50mcg; 100mcg; 200mcg | Rare endocrine / acromegaly or neuroendocrine tumor |
| Erythropoietin | (2000; 3000; 4000; 5000; 10000; 20000; 40000) IU/ml | Rare hematology / anemia syndromes |
| Filgrastim | 300mcg/1ml | Rare hematology / severe congenital neutropenia |
| Azacitidine Injection (Lyophilized) | 100 mg | Rare oncology / myelodysplastic syndromes |
| Bortezomib Injection | 2mg; 3.5mg | Rare oncology / multiple myeloma |
| Desferrioxamine Injection | 500 mg | Rare hematology / transfusional iron overload |
| Interferon Beta Injection | 30mcg | Rare neurologic / demyelinating disease |
| Melphalan Injection | 50 mg | Rare oncology / multiple myeloma |
| Pegaspargase Injection | 3,750 IU | Rare oncology / acute lymphoblastic leukemia |
| Thiotepa Injection (Lyophilized) | 15mg; 100 mg | Rare oncology / transplant conditioning or rare cancers |
| Tocilizumab Injection | 200 mg/10 ml | Rare inflammatory / Castleman disease or systemic JIA |
| Chlorambucil | 20mg | Rare oncology / hematologic malignancy |
| Fludarabine Phosphate | 10mg | Rare oncology / hematologic malignancy |
| Imatinib | 100mg; 400mg | Rare oncology / CML or GIST |
| Tretinoin | 10mg; 20mg | Rare oncology / acute promyelocytic leukemia |
| Alfacalcidol | 0.25mcg; 0.5mcg; 1mcg | Rare endocrine / hypoparathyroidism-related use |
| Deflazacort | 1mg; 6mg; 12mg; 18mg; 30mg | Rare genetic neuromuscular disease / Duchenne muscular dystrophy |
| Acitretin | 10mg; 25mg | Rare dermatology / disorders of keratinization |
| Deferiprone | 250mg | Rare hematology / transfusional iron overload |
| Nilotinib | 200mg | Rare oncology / CML |
| Crizotinib | 250mg | Rare oncology / ALK-positive tumors |
| Etoposide | 50mg; 100mg | Rare oncology / hematologic or germ-cell malignancy |
| Hydroxyurea | 250mg; 500mg | Rare hematology / sickle cell disease or myeloproliferative neoplasm |
| Imatinib Mesylate | 100mg; 400mg | Rare oncology / CML or GIST |
| Lenalidomide | 10mg; 15mg | Rare oncology / multiple myeloma or MDS |
| Lenvatinib | 10 mg | Rare oncology / thyroid cancer |
| Procarbazine | 50mg | Rare oncology / Hodgkin lymphoma or brain tumors |
| Sunitinib | 12.5mg; 25mg; 37.5mg; 50mg | Rare oncology / GIST or pancreatic NET |
| Temozolomide | 20mg; 100mg; 250mg | Rare oncology / glioma |
| Thalidomide | 50mg; 100mg; 150mg; 200mg; 300mg | Rare oncology / multiple myeloma; rare inflammatory use |
